“Renal safety of combined cyclooxygenase 2 (COX-2) inhibitor and angiotensin II receptor blocker administration in mild volume depletion” (2001) Swiss Medical Weekly, 131(1314), pp. 193–198. doi:10.4414/smw.2001.09680.